Indication
Pediatric Brain Stem Tumor
1 clinical trial
1 product
Product
NEO100Clinical trial
An Open Label, Phase 1b Safety, Dose-finding, Brain Tumor Delivery, and Pharmacokinetics Study of Intranasal NEO100 in Patients With Pediatric-type Select Brain TumorsStatus: Not yet recruiting, Estimated PCD: 2024-10-31